Has John Santoro, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $20,768 in general payments to John Santoro, DPM across 417 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Santoro, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Santoro, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Santoro, DPM

Foot & Ankle Surgery · Murrieta, CANPI 1548271828

Payments from drug & device makers

$20,768in general payments, 2019–2025

Across 417 payments — averaging $49.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Averitas Pharma Inc.$8K
GRT US Holding, Inc.$2K
Smith+Nephew$1K
Vilex LLC$1K
Stryker$810
Amgen$807
plus $6K from 42 others

What the payments were for

Consulting fees$2,00010%
Speaking & faculty fees$5,86528%
Travel & lodging$2,91714%
Food & beverage$8,77342%
Education$1,2126%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Averitas Pharma Inc.	19	$7,889
GRT US Holding, Inc.	11	$2,337
Smith+Nephew	109	$1,440
Vilex LLC	11	$1,086
Stryker(2 entities)	17	$810
Amgen(2 entities)	53	$807
Sportstek Medical, Inc	1	$640
Empire Medical, Inc	1	$549
Paratek Pharmaceuticals, Inc.	18	$527
Fusion Orthopedics USA, LLC	5	$525
AbbVie(2 entities)	29	$499
Integra Lifesciences Corporation	9	$406
Treace Medical Concepts, Inc.	12	$376
Viiv Healthcare Company	10	$243
La Jolla Pharmaceutical Company	9	$234
Theratechnologies Inc.	9	$198
In2bones USA, LLC	2	$172
Acera Surgical, Inc.	3	$160
Johnson & Johnson	5	$159
Zyla Life Sciences, Inc.	23	$154
Tactile Systems Technology Inc	9	$146
Cumberland Pharmaceuticals, Inc.	4	$141
Derma Sciences, Inc.	1	$109
Merck	5	$107
Tetraphase Pharmaceuticals, Inc.	5	$107
Melinta Therapeutics, LLC	5	$100
Ferring Pharmaceuticals Inc.	2	$100
Janssen Scientific Affairs, LLC	1	$77
Sanara Medtech Inc.	1	$73
Biotissue Holdings Inc.	3	$67
Organogenesis Inc.	2	$50
Alfasigma USA, Inc.	3	$50
Inari Medical, Inc.	1	$50
Davol Inc.	2	$46
Linvatec Corporation	2	$45
Bioventus LLC	2	$38
Astellas Pharma US Inc	2	$36
Kerecis Limited	1	$27
Medtronic	1	$26
Convatec Inc.	1	$25
Nabriva Therapeutics, PLC	1	$24
Access Pro Medical, LLC	1	$22
Nevro Corp.	1	$21
Vital Orthopedics LLC	1	$20
Assertio Therapeutics, Inc.	1	$15
Pfizer	1	$12
Zimmer Biomet	1	$12
Acell, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,768 in reported general payments places this provider in the 90th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California →

Medicare billing

Part B allowed, 2024

$257,463

Medicare patients

513

Services billed

9,093

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	21	$125
Clindamycin Hcl	11	$125
Gabapentin	13	$99
Cephalexin	12	$68

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Murrieta

Daniel TuckerMurrieta$76K
John ZimmermanBakersfield$4.6M
Eric GizaSacramento$3.7M
Thomas HarrisPasadena$3M
Felix SigalLos Angeles$2.2M
Thomas ChangSanta Rosa$2.1M
Michael CoughlinSan Francisco$1.6M
Vladimir ZeetserEncino$677K
Jason NowakRedding$526K
Candice BradyCamarillo$462K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →